CGEM Cullinan Therapeutics, Inc. - Common Stock
$14.74
Price · May 20, 2026
Fundamentals as of May 7, 2026
52W Range
$6–$17
82% of range
Analyst Rating
STRONG BUY
19 analysts
Price Target
$32
+114% upside
P/E (TTM)
-3.2
ROE
-44.0%
Net Profit Margin
—
CGEM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$14.74
Market Cap
$624M
P/E (TTM)
-3.2
EPS (TTM)
$-3.69
Revenue (TTM)
—
Div Yield
—
ROE
-44.0%
Debt/Equity
—
52W Range
$6 – $17
CGEM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
2020-12-31
→
2022-12-31
EPS
$-3.69
2021-12-31
→
2023-12-31
Free Cash Flow
$-176M
2022-12-31
→
2025-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
CGEM
Peer Median
P/E (TTM)
-3.2
86.6
P/B
1.5
4.0
Price / FCF
-3.5
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
CGEM
Peer Median
ROA
-41.1%
-38.7%
ROE
-44.0%
-46.2%
ROIC
-59.1%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
CGEM
Peer Median
Current Ratio
10.2
9.5
Quick Ratio
10.0
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
CGEM
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
CGEM
Peer Median
CGEM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
19 analysts
- Strong Buy 9 47.4%
- Buy 9 47.4%
- Hold 1 5.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
11 analysts · 2026-05-15
Median
$30.00
Mean
$31.55
← Below all targets
$14.74
Low
$24.00
High
$38.00
Median target
$30.00
+103.5%
Mean target
$31.55
+114.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.04%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.75 | $-0.85 | 0.10% |
| Dec. 31, 2025 | $-0.77 | $-0.83 | 0.06% |
| Sept. 30, 2025 | $-0.77 | $-0.98 | 0.21% |
| June 30, 2025 | $-1.07 | $-0.85 | -0.22% |
| March 31, 2025 | $-0.74 | $-0.82 | 0.08% |
| Dec. 31, 2024 | $-0.73 | $-0.77 | 0.04% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CGEM | $624M | -3.2 | — | — | -44.0% | — |
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | — |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | — |
| ORIC | $806M | -5.6 | — | — | -36.5% | — |
| ANNX | $750M | -3.7 | — | — | -100.7% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 15
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $19M | $0 | |
| R&D Expense | $187M | $143M | $148M | $92M | $58M | $43M | |
| SG&A Expense | $54M | $54M | $42M | $40M | $29M | $17M | |
| Operating Expenses | $242M | $197M | $191M | $132M | $87M | $60M | |
| Operating Income | $-242M | $-197M | $-191M | $145M | $-68M | $-60M | |
| Interest Income | $22M | $30M | $22M | $7M | $477.0K | $888.0K | |
| Other Non-op | $-443.0K | $-199.0K | $239.0K | $57.0K | $-8.0K | $-11.0K | |
| Pretax Income | $-220M | $-167M | $-169M | $151M | $-67M | · | |
| Income Tax | $0 | $117.0K | $-14M | $42M | $0 | · | |
| Net Income | $-220M | $-167M | $-153M | $111M | $-66M | $-52M | |
| EPS (Basic) | · | · | $-3.69 | $2.46 | $-1.52 | · | |
| EPS (Diluted) | · | · | $-3.69 | $2.38 | $-1.52 | · | |
| Shares (Basic) | · | · | 41,550,000 | 45,164,000 | 43,077,000 | · | |
| Shares (Diluted) | · | · | 41,550,000 | 46,640,000 | 43,077,000 | · | |
| EBITDA | $-241M | $-197M | $-191M | $145M | $-68M | · |
Balance Sheet 21
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $83M | $98M | $156M | $60M | $168M | |
| Short-term Investments | $290M | $316M | $369M | $311M | $231M | $42M | |
| Prepaid Expense | $9M | $16M | $13M | $7M | $6M | $2M | |
| Other Current Assets | · | · | $4M | · | · | · | |
| Current Assets | $387M | $415M | $480M | $474M | $297M | $212M | |
| PP&E (Net) | $421.0K | $683.0K | $989.0K | $1M | $77.0K | $130.0K | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $309.0K | $309.0K | |
| Accum. Depreciation | $969.0K | $658.0K | $352.0K | $135.0K | $232.0K | $179.0K | |
| Other Non-current Assets | $297.0K | $366.0K | $459.0K | $459.0K | $147.0K | $2M | |
| Total Assets | $448M | $622M | $484M | $561M | $437M | $215M | |
| Accounts Payable | $841.0K | $2M | $2M | $3M | $3M | $10M | |
| Accrued Liabilities | $36M | $28M | $24M | $14M | $9M | $5M | |
| Current Liabilities | $38M | $31M | $28M | $22M | $12M | $14M | |
| Capital Leases | $2M | $849.0K | $2M | $4M | · | · | |
| Total Liabilities | $40M | $31M | $30M | $26M | $12M | $14M | |
| Common Stock | $6.0K | $6.0K | $4.0K | $5.0K | $4.0K | $3.0K | |
| Retained Earnings | $-588M | $-368M | $-201M | $-48M | $-159M | $-93M | |
| AOCI | $1M | $-133.0K | $-129.0K | $-3M | $-838.0K | $-2.0K | |
| Stockholders' Equity | $409M | $590M | $454M | $535M | $425M | $199M | |
| Liabilities + Equity | $448M | $622M | $484M | $561M | $437M | $215M | |
| Shares Outstanding | 60,244,136 | 58,510,610 | 42,900,083 | 45,796,449 | 44,292,102 | 29,831,125 |
Cash Flow 13
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $311.0K | $306.0K | $310.0K | $93.0K | $53.0K | $62.0K | |
| Stock-based Comp | $36M | $38M | $30M | $28M | $24M | $15M | |
| Deferred Tax | · | $3M | $5M | · | $0 | $0 | |
| Other Non-cash | $8M | $-19M | $-17M | $-266M | $-2M | · | |
| Operating Cash Flow | $-176M | $-145M | $-134M | $-127M | $-43M | $-30M | |
| CapEx | $49.0K | $0 | $208.0K | $1M | $0 | $10.0K | |
| Investing Cash Flow | $180M | $-136M | $36M | $249M | $-334M | $-5M | |
| Stock Issued | $0 | $263M | $38M | $0 | $3M | $145M | |
| Stock Repurchased | · | · | · | · | · | $7M | |
| Net Stock Activity | $0 | $263M | $38M | $6M | · | · | |
| Financing Cash Flow | $1M | $266M | $41M | $-26M | $269M | $140M | |
| Taxes Paid | $-3M | $-2M | $-4M | $38M | $0 | · | |
| Free Cash Flow | $-176M | $-145M | $-134M | $-128M | · | · |
Profitability 6
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -358.7% | · | |
| Net Margin | · | · | · | · | -346.1% | · | |
| EBITDA Margin | · | · | · | · | -358.4% | · | |
| ROA | -41.1% | -30.3% | -29.3% | 22.3% | -20.1% | · | |
| ROE | -44.0% | -32.1% | -31.0% | 23.2% | -21.0% | · | |
| ROIC | -59.1% | -33.4% | -38.6% | 19.5% | · | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 13.5 | 17.1 | 21.1 | 25.2 | · | |
| Quick Ratio | 10.0 | 13.0 | 16.6 | 20.8 | 24.7 | · |
Efficiency 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | · |
Valuation (TTM) 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $19M | $0 | |
| Net Income TTM | $-220M | $-167M | $-153M | $111M | $-66M | $-52M | |
| Market Cap | $624M | $713M | $437M | $483M | $683M | · | |
| P/E | -3.2 | -3.8 | -2.8 | 4.4 | -10.2 | · | |
| P/S | · | · | · | · | 36.1 | · | |
| P/B | 1.5 | 1.2 | 1.0 | 0.9 | 1.6 | · | |
| P / Tangible Book | 1.5 | 1.2 | 1.0 | 0.9 | 1.6 | · | |
| P / Cash Flow | -3.5 | -4.9 | -3.3 | -3.8 | -15.7 | · | |
| P / FCF | -3.5 | -4.9 | -3.3 | -3.8 | · | · | |
| Earnings Yield | -31.0% | -26.4% | -36.2% | 22.6% | -9.8% | · |
Income Statement 15
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| R&D Expense | $42M | $43M | $42M | $61M | $41M | $40M | $36M | $36M | $31M | $35M | $34M | $27M | $52M | $21M | $20M | $26M | |
| SG&A Expense | $12M | $12M | $14M | $15M | $14M | $15M | $13M | $14M | $12M | $11M | $11M | $10M | $11M | $11M | $10M | $11M | |
| Operating Expenses | $54M | $55M | $56M | $76M | $55M | $55M | $49M | $50M | $43M | $45M | $45M | $38M | $63M | $33M | $30M | $37M | |
| Operating Income | $-54M | $-55M | $-56M | $-76M | $-55M | $-55M | $-49M | $-50M | $-43M | $-45M | $-45M | $-38M | $-63M | $-33M | $-30M | $240M | |
| Interest Income | $4M | $5M | $5M | $6M | $7M | $8M | $8M | $8M | $6M | $6M | $6M | $5M | $5M | $3M | $2M | $697.0K | |
| Other Non-op | $-62.0K | $-69.0K | $-108.0K | $-181.0K | $-85.0K | $6.0K | $-89.0K | $-72.0K | $-44.0K | $-117.0K | $180.0K | $69.0K | $107.0K | $298.0K | $0 | $-241.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | $-40M | $-39M | $-32M | $-58M | $-29M | $-27M | $240M | |
| Income Tax | · | · | · | · | · | · | · | · | · | $-14M | $0 | $0 | $0 | $-2M | $-3M | $66M | |
| Net Income | $-50M | $-51M | $-51M | $-70M | $-49M | $-48M | $-41M | $-42M | $-37M | $-24M | $-39M | $-32M | $-58M | $-27M | $-25M | $175M | |
| EPS (Basic) | · | · | · | · | · | · | $-0.69 | $-0.75 | $-0.86 | · | $-0.91 | $-0.82 | $-1.42 | $-0.63 | $-0.54 | $3.90 | |
| EPS (Diluted) | · | · | · | · | · | · | $-0.69 | $-0.75 | $-0.86 | · | $-0.91 | $-0.82 | $-1.42 | $-0.58 | $-0.54 | $3.77 | |
| Shares (Basic) | · | · | · | · | · | · | 58,337,000 | 55,052,000 | 43,011,000 | · | 42,734,000 | 39,952,000 | 40,682,000 | -89,752,000 | 45,611,000 | 44,873,000 | |
| Shares (Diluted) | · | · | · | · | · | · | 58,337,000 | 55,052,000 | 43,011,000 | · | 42,734,000 | 39,952,000 | 40,682,000 | -89,784,000 | 45,611,000 | 46,381,000 | |
| EBITDA | $-54M | · | $-56M | $-76M | $-55M | · | $-49M | $-50M | $-43M | · | $-45M | $-38M | $-63M | · | $-30M | $240M |
Balance Sheet 20
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $75M | $88M | $103M | $73M | $77M | $83M | $102M | $115M | $74M | $98M | $65M | $142M | $122M | $156M | $243M | $354M | |
| Short-term Investments | $277M | $290M | $229M | $193M | $227M | $316M | $476M | $547M | $359M | $369M | $402M | $350M | $269M | $311M | $333M | $257M | |
| Prepaid Expense | $10M | $9M | $10M | $10M | $14M | $16M | $14M | $15M | $13M | $13M | $619.0K | $619.0K | $8M | · | $619.0K | $619.0K | |
| Current Assets | $361M | $387M | $342M | $276M | $318M | $415M | $592M | $678M | $446M | $480M | $477M | $498M | $399M | $474M | $582M | $623M | |
| PP&E (Net) | $342.0K | $421.0K | $489.0K | $569.0K | $607.0K | $683.0K | $760.0K | $836.0K | $913.0K | $989.0K | $1M | $1M | $1M | $1M | $792.0K | $52.0K | |
| PP&E (Gross) | · | $1M | · | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Accum. Depreciation | · | $969.0K | · | · | · | $658.0K | · | · | · | $352.0K | · | · | · | $135.0K | · | · | |
| Other Non-current Assets | $297.0K | $297.0K | $361.0K | $367.0K | $366.0K | $366.0K | $460.0K | $460.0K | $460.0K | $459.0K | $459.0K | $459.0K | $459.0K | $459.0K | $460.0K | $100.0K | |
| Total Assets | $403M | $448M | $484M | $520M | $580M | $622M | $653M | $681M | $449M | $484M | $495M | $522M | $515M | $561M | $617M | $667M | |
| Accounts Payable | $3M | $841.0K | $2M | $2M | $3M | $2M | $2M | $2M | $4M | $2M | $951.0K | $2M | $2M | $3M | $2M | $3M | |
| Accrued Liabilities | $32M | $36M | $30M | $24M | $23M | $28M | $21M | $21M | $17M | $24M | $21M | $16M | $18M | $14M | $14M | $12M | |
| Current Liabilities | $35M | $38M | $33M | $28M | $27M | $31M | $24M | $23M | $22M | $28M | $23M | $20M | $26M | $22M | $27M | $62M | |
| Capital Leases | $2M | $2M | $0 | $125.0K | $493.0K | $849.0K | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $596.0K | |
| Total Liabilities | $37M | $40M | $33M | $28M | $28M | $31M | $25M | $25M | $24M | $30M | $26M | $22M | $29M | $26M | $31M | $63M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $5.0K | $5.0K | $5.0K | |
| Retained Earnings | $-638M | $-588M | $-537M | $-487M | $-417M | $-368M | $-321M | $-280M | $-238M | $-201M | $-177M | $-138M | $-106M | $-48M | $-21M | $4M | |
| AOCI | $127.0K | $1M | $973.0K | $607.0K | $505.0K | $-133.0K | $970.0K | $-476.0K | $-331.0K | $-129.0K | $-1M | $-2M | $-1M | $-3M | $-4M | $-4M | |
| Stockholders' Equity | $366M | $409M | $451M | $492M | $552M | $590M | $628M | $656M | $426M | $454M | $469M | $500M | $486M | $535M | $586M | $605M | |
| Liabilities + Equity | $403M | $448M | $484M | $520M | $580M | $622M | $653M | $681M | $449M | $484M | $495M | $522M | $515M | $561M | $617M | $667M | |
| Shares Outstanding | 61,451,380 | 60,244,136 | 59,076,259 | 59,074,391 | 58,698,919 | 58,510,610 | 58,141,130 | 57,871,638 | 43,065,645 | 42,900,083 | 42,760,644 | 42,735,304 | 39,343,601 | 45,796,449 | 45,743,027 | 45,396,398 |
Cash Flow 12
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $79.0K | $79.0K | $79.0K | $77.0K | $76.0K | $77.0K | $76.0K | $77.0K | $76.0K | $77.0K | $80.0K | $81.0K | $72.0K | $59.0K | $9.0K | $12.0K | |
| Stock-based Comp | $8M | $7M | $9M | $10M | $9M | $10M | $9M | $11M | $8M | $8M | $8M | $8M | $7M | $8M | $5M | $9M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Other Non-cash | $-4M | · | · | · | $-4M | · | · | · | $-9M | · | · | · | $-366.0K | · | · | · | |
| Operating Cash Flow | $-46M | $-38M | $-37M | $-58M | $-43M | $-37M | $-34M | $-36M | $-38M | $-18M | $-34M | $-31M | $-51M | $-25M | $-54M | $-25M | |
| CapEx | · | $11.0K | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $49.0K | $159.0K | $882.0K | $251.0K | $0 | |
| Investing Cash Flow | $32M | $22M | $67M | $53M | $37M | $16M | $20M | $-185M | $13M | $51M | $-43M | $12M | $15M | $-29M | $-58M | $301M | |
| Stock Issued | · | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | $38M | $-36.0K | $0 | $-4M | $-2M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $-36.0K | · | · | · | |
| Financing Cash Flow | $380.0K | $715.0K | $0 | $373.0K | $0 | $2M | $1M | $262M | $1M | $248.0K | $112.0K | $39M | $2M | $-33M | $1M | $2M | |
| Taxes Paid | · | $0 | $0 | $-3M | $0 | $0 | $0 | $2M | $-4M | $-9M | $0 | $5M | $75.0K | $5M | $33M | $0 | |
| Free Cash Flow | · | · | · | · | · | · | · | · | $-38M | · | · | · | $-51M | · | · | · |
Profitability 3
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.1% | · | -8.9% | -11.7% | -9.4% | · | -7.1% | -7.0% | -7.7% | · | -7.0% | -5.4% | -12.2% | · | -4.6% | 30.9% | |
| ROE | -10.8% | · | -9.4% | -12.2% | -9.9% | · | -7.4% | -7.3% | -8.2% | · | -7.4% | -5.8% | -12.8% | · | -4.8% | 33.0% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | -9.7% | -7.5% | -12.9% | · | -4.6% | 28.7% |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | · | 10.4 | 9.8 | 11.6 | · | 24.5 | 28.9 | 20.3 | · | 20.3 | 25.3 | 15.2 | · | 21.5 | 10.0 | |
| Quick Ratio | 10.0 | · | 10.2 | 9.5 | 11.1 | · | 23.9 | 28.2 | 19.7 | · | 19.9 | 25.0 | 14.9 | · | 21.2 | 9.8 |
Efficiency 1
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 |
Valuation (TTM) 9
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | |
| Net Income TTM | $-219M | · | $-210M | $-201M | $-168M | · | $-159M | $-151M | $-167M | · | $-154M | $60M | $80M | · | $121M | $130M | |
| Market Cap | $873M | · | $350M | $445M | $444M | · | $973M | $1.01B | $734M | · | $387M | $460M | $402M | · | $586M | $582M | |
| P/E | -4.4 | · | -1.8 | -2.3 | -2.4 | · | -5.2 | -5.2 | -4.2 | · | -2.5 | 10.9 | 6.6 | · | 5.0 | 4.7 | |
| P/B | 2.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 1.5 | 1.7 | · | 0.8 | 0.9 | 0.8 | · | 1.0 | 1.0 | |
| P / Tangible Book | 2.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 1.5 | 1.7 | · | 0.8 | 0.9 | 0.8 | · | 1.0 | 1.0 | |
| P / Cash Flow | -19.0 | · | · | · | -10.3 | · | · | · | -19.2 | · | · | · | -7.9 | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | -19.2 | · | · | · | -7.9 | · | · | · | |
| Earnings Yield | -22.6% | · | -54.1% | -42.6% | -42.4% | · | -19.2% | -19.1% | -23.5% | · | -40.8% | 9.2% | 15.0% | · | 20.0% | 21.4% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $19M |
| Operating Margin % | — | — | — | — | -358.7% |
| Net Income | $-220M | $-167M | $-153M | $111M | $-66M |
| Diluted EPS | — | — | $-3.69 | $2.38 | $-1.52 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 10.2 | 13.5 | 17.1 | 21.1 | 25.2 |
| Quick Ratio | 10.0 | 13.0 | 16.6 | 20.8 | 24.7 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $-176M | $-145M | $-134M | $-128M | — |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.